Pharma Journalist 8769 posts 0 comments

AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated under which AGI will now acquire the residual rights to the established anaesthetic medicines…
Read More...

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed…
Read More...

Immunocore Limited announced an investment from the Bill & Melinda Gates Foundation to support the development of Immunocore's soluble TCR-based therapeutics for infectious…
Read More...

Regeneron Pharmaceuticals and Sanofi announced positive results from the Phase 3 CAFÉ study of DUPIXENT® (dupilumab) in adults with moderate-to-severe atopic dermatitis (AD) who are…
Read More...

Thrombolytic Science, LLC (TSI) announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the treatment of clot-induced diseases…
Read More...

Eurofins Scientific announces that it has signed an agreement to acquire EAG Laboratories from Odyssey Investment Partners. The transaction is expected to close in the next few months,…
Read More...

Absorption Systems announces a formal Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). The goals are to improve the FDA's ability to predict…
Read More...

Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced that it has entered into an option and…
Read More...

FUJIFILM Diosynth Biotechnologies has announced its opening of the 10,000 square foot, state-of-the-art cell culture Process Development Laboratories in Wilton Centre, Teesside. These…
Read More...

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing…
Read More...